中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2011年
22期
3025-3026
,共2页
阿依努尔·艾买提%木巴拉克·派祖拉%艾克拜尔·安扎尔
阿依努爾·艾買提%木巴拉剋·派祖拉%艾剋拜爾·安扎爾
아의노이·애매제%목파랍극·파조랍%애극배이·안찰이
白癜风%催乳素%免疫%内分泌
白癜風%催乳素%免疫%內分泌
백전풍%최유소%면역%내분비
Vitiligo%Prolactin%Immune%Endocrine
目的 探讨血清催乳素(PRL)水平与进展期白癜风发生发展的关系.方法 采用化学发光法测定205例进展期白癜风患者(病例组)的PRL水平,并与健康对照组(98例)比较.结果 (1)对照组与病例组催乳素水平数据样本均数及总体分布差异有统计学意义(P＜0.05),并且病例组水平[( 275.96±178.51) μIU/ml]低于对照组[(282.98±115.39) μIU/ml]；(2)女性病例组的催乳素水平[(288.68±198.45) μIU/ml]与女性对照组[(303.82±121.62)μIU/ml]差异有统计学意义(P＜0.05).男性病例组催乳素水平[ (256.54±141.72) μIU/ml]与男性对照组[(236.43±84.67) μIU/ml]差异则无统计学意义(P＞0.05).结论 催乳素可能并非直接参与或导致白癜风发生及发展.因此它无法作为一项诊断检测指标用于衡量白癜风患病程度,更无法作为中医或维吾尔医学理论中各白癜风辨证分型的诊断依据.
目的 探討血清催乳素(PRL)水平與進展期白癜風髮生髮展的關繫.方法 採用化學髮光法測定205例進展期白癜風患者(病例組)的PRL水平,併與健康對照組(98例)比較.結果 (1)對照組與病例組催乳素水平數據樣本均數及總體分佈差異有統計學意義(P＜0.05),併且病例組水平[( 275.96±178.51) μIU/ml]低于對照組[(282.98±115.39) μIU/ml]；(2)女性病例組的催乳素水平[(288.68±198.45) μIU/ml]與女性對照組[(303.82±121.62)μIU/ml]差異有統計學意義(P＜0.05).男性病例組催乳素水平[ (256.54±141.72) μIU/ml]與男性對照組[(236.43±84.67) μIU/ml]差異則無統計學意義(P＞0.05).結論 催乳素可能併非直接參與或導緻白癜風髮生及髮展.因此它無法作為一項診斷檢測指標用于衡量白癜風患病程度,更無法作為中醫或維吾爾醫學理論中各白癜風辨證分型的診斷依據.
목적 탐토혈청최유소(PRL)수평여진전기백전풍발생발전적관계.방법 채용화학발광법측정205례진전기백전풍환자(병례조)적PRL수평,병여건강대조조(98례)비교.결과 (1)대조조여병례조최유소수평수거양본균수급총체분포차이유통계학의의(P＜0.05),병차병례조수평[( 275.96±178.51) μIU/ml]저우대조조[(282.98±115.39) μIU/ml]；(2)녀성병례조적최유소수평[(288.68±198.45) μIU/ml]여녀성대조조[(303.82±121.62)μIU/ml]차이유통계학의의(P＜0.05).남성병례조최유소수평[ (256.54±141.72) μIU/ml]여남성대조조[(236.43±84.67) μIU/ml]차이칙무통계학의의(P＞0.05).결론 최유소가능병비직접삼여혹도치백전풍발생급발전.인차타무법작위일항진단검측지표용우형량백전풍환병정도,경무법작위중의혹유오이의학이론중각백전풍변증분형적진단의거.
Objective To explore the relation between the serum prolactin level and the development of aggressive-phase vitiligo.Methods The peripheral blood serum of 205 aggressive-phase vitiligo patients ( trial group) and 98 healthy volunteer(control group) were assayed by chemiluminescence analysis.Results ( 1 ) The data of the prolactin levels and the overall distribution of sample mean had statistically significant differences between the control group and trial group( P ＜ 0.05 ).The PRL level of the trial group [ ( 275.96 ± 178.51 ) μIU/ml ] was significantly lower than that of the control group [ (282.98 ± 115.39)μIU/ml ] ( P ＜ 0.05 ).(2) The PRL level of the female trial group[ (288.68 ± 198.45) μ IU/ml]was significantly different from the female control group[ (303.82 ± 121.62)μIU/ml] ( P ＜ 0.05),and the PRL level between the male trial group [ (256.54 ± 141.72) μIU/ml] and the male control group [ (236.43 ± 84.67 ) μIU/ml ] had no significant differences ( P ＞ 0.05 ).Conclusion PRL should not directly result in or participate in development of vitiligo.So it could not be a diagnostic tests to measure the stage of vitiligo and the diagnosis basis for vitiligo's syndrome differentiation of chinese-medicine or Uygur-medicine.
